News & Events



BD to Present at Investor Healthcare Conferences


Contact: Monique N. Dolecki
Investor Relations
(201) 847-5378
Email: monique_dolecki@bd.com

Colleen T.  White
Corporate Communications
(201) 847-5369
Email: colleen_white@bd.com

FranklinLakes, NJ (February 10, 2012) – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following investor healthcare conferences in February 2012:

    Leerink Swann 2012 Global Healthcare Conference
    February 15, 2012
    10:30 a.m. ET

    Citi 2012 Global Healthcare Conference
    February 28, 2012
    10:00 a.m. ET

Live webcasts of BD’s presentations can be accessed on the BD corporate website at www.bd.com/investors.  They will be available for replay for a period of seven days after each conference.  

About BD

BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in more than 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. For more information, please visit www.bd.com.

 

Unless otherwise noted, BD, BD Logo and all other trademarks are property of Becton, Dickinson and Company. © 2014 BD